Peptide directoryBrain, hypothalamus & pituitary

NERP-2

A second vasopressin-restraining VGF peptide that also drives feeding.

Where it comes from

Made in
Hypothalamus, posterior pituitary and the adrenal
Sent out by
With vasopressin; fasting raises it
Acts on
  • Vasopressin neurons
  • Orexin neurons of the lateral hypothalamus
  • Islets (insulin, in vitro)

What it does

  • Suppresses vasopressin release like NERP-1 1
  • Increases food intake and locomotion through orexin 2
  • Enhances glucose-stimulated insulin release in islets 3

In medicine

  • No medicine copies it or blocks it, and it is not measured in people
  • It has no identified receptor. Its feeding effect is abolished by an orexin receptor blocker, so what it binds first is still unknown 2

Beyond the body’s own use

  • Nothing containing it is in trials, approved or obtainable outside the laboratory
  • It is the more interesting half of the pair: as well as restraining vasopressin like NERP-1, it increases food intake and movement, and that effect disappears when orexin signalling is blocked, which places it upstream of the wake-and-feed system 2
  • What is unknown is how one precursor coordinates three jobs. VGF yields NERP-1, NERP-2 and TLQP-21, which act on water balance, feeding and fat, and nothing is known about what decides which of them a cell makes 3

Sources

  1. Yamaguchi et al., Peptidomic identification and biological validation of neuroendocrine regulatory peptide-1 and -2, Journal of Biological Chemistry 2007
  2. Toshinai et al., Neuroendocrine regulatory peptide-2 regulates feeding behaviour via the orexin system, American Journal of Physiology 2010
  3. Toshinai & Nakazato, Neuroendocrine regulatory peptide-1 and -2, bioactive peptides processed from VGF, Cellular and Molecular Life Sciences 2009

This card describes what a medicine is for and what the evidence says; it recommends nothing. Talk to your clinician about anything you read here.